The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
87677972 8767797 2 F 20110928 20131211 20120905 20160722 EXP DE-ROCHE-1113050 ROCHE 19.58 YR M Y 97.90000 KG 20160722 MD DE DE

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
87677972 8767797 1 PS VALGANCICLOVIR. VALGANCICLOVIR 1 Unknown U 21304 450 MG
87677972 8767797 2 SS METHYLPREDNISOLONE. METHYLPREDNISOLONE 1 Oral DATE OF LAST DOSE PRIOR TO SAE: 28/SEP/2011 U 0 5 MG QD
87677972 8767797 3 SS TACROLIMUS. TACROLIMUS 1 Oral DRUG: TACROLIMUS PROGRAF, DATE OF LAST DOSE PRIOR TO SAE: 28/SEP/2011 U 0 3 MG QD
87677972 8767797 4 SS MYCOPHENOLATE MOFETIL. MYCOPHENOLATE MOFETIL 1 Unknown U 50722
87677972 8767797 5 C CANDIO HERMAL 2 Oral DOSE: 3X1 PIP, DATE OF LAST DOSE PRIOR TO SAE: 28/SEP/2011 0 QD
87677972 8767797 6 C CANDIO HERMAL 2 Oral DOSE: 3X1 PIP, DATE OF LAST DOSE PRIOR TO SAE: 28/SEP/2011, DRUG INDICATION: APHTHEN 0 QD
87677972 8767797 7 C ROCEPHIN CEFTRIAXONE SODIUM 1 Oral DATE OF LAST DOSE PRIOR TO SAE: 28/SEP/2011 0 20 ML QD
87677972 8767797 8 C BICANORM SODIUM BICARBONATE 1 Oral DATE OF LAST DOSE PRIOR TO SAE: 28/SEP/2011 0 2 G QD
87677972 8767797 9 C ZANTAC RANITIDINE HYDROCHLORIDE 1 Oral DATE OF LAST DOSE PRIOR TO SAE: 28/SEP/2011 0 150 MG QD
87677972 8767797 10 C VIGANTOLETTEN CHOLECALCIFEROL 1 Oral DOSE: 2000E, DATE OF LAST DOSE PRIOR TO SAE: 28/SEP/2011 0 QD
87677972 8767797 11 C FORTUM CEFTAZIDIME 1 Intravenous (not otherwise specified) DATE OF LAST DOSE PRIOR TO SAE: 28/SEP/2011 0 5 MG QD
87677972 8767797 12 C AMPICILLIN AMPICILLIN 1 Intravenous (not otherwise specified) DATE OF LAST DOSE PRIOR TO SAE: 28/SEP/2011 0 9 G QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
87677972 8767797 1 Infection in an immunocompromised host
87677972 8767797 2 Prophylaxis against transplant rejection
87677972 8767797 3 Prophylaxis against transplant rejection
87677972 8767797 4 Product used for unknown indication
87677972 8767797 5 Prophylaxis
87677972 8767797 7 Prophylaxis
87677972 8767797 8 Metabolic acidosis
87677972 8767797 9 Prophylaxis
87677972 8767797 10 Hyperparathyroidism secondary

Outcome of event

Event ID CASEID OUTC COD
87677972 8767797 HO
87677972 8767797 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
87677972 8767797 Acne
87677972 8767797 Agranulocytosis
87677972 8767797 BK virus infection
87677972 8767797 Epstein-Barr virus infection
87677972 8767797 Hyperparathyroidism secondary
87677972 8767797 Leukopenia
87677972 8767797 Metabolic acidosis
87677972 8767797 Viral sepsis

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
87677972 8767797 2 20110613 0
87677972 8767797 3 20110617 0
87677972 8767797 5 20110613 0
87677972 8767797 6 20110928 0
87677972 8767797 7 20110613 0
87677972 8767797 8 20110707 0
87677972 8767797 9 20110721 0
87677972 8767797 10 20110831 0
87677972 8767797 11 20110928 0
87677972 8767797 12 20110928 0